nu-derm system normal-dry skin transformation HYDROQUINONE OCTISALATE AND ZINC OXIDE OBAGI COSMECEUTICAL LLC FDA Approved Hydroquinone, USP 4% is 1, 4-benzenediol. The drug is freely soluble in water and in alcohol. Chemically, hydroquinone is designated as p-dihydroxybenzene; the empirical formula is C 6 H 6 O 2 ; molecular weight is 110.11 g/mol. The chemical structure is in the diagram below. Chemical Structure Each gram of Obagi Nu-Derm ® Clear contains: ACTIVE: Hydroquinone, USP 4% (40 mg/g) INACTIVES: ascorbic acid, BHT, butylparaben, cetyl alcohol, disodium EDTA, glycerin, lactic acid, methylparaben, propylparaben, saponins, sodium lauryl sulfate, sodium metabisulfite, stearyl alcohol, tocopheryl acetate, water (aqua) Each gram of Obagi Nu-Derm Blender ® contains: ACTIVE: Hydroquinone, USP 4% (40 mg/g) INACTIVES: ascorbic acid, BHT, cetyl alcohol, disodium EDTA, glycerin, lactic acid, methylparaben, phenyl trimethicone, PPG-2 myristyl ether propionate, propylparaben, saponins, sodium lauryl sulfate, sodium metabisulfite, TEA-salicylate, tocopheryl acetate, water (aqua) Each gram of Obagi Nu-Derm ® Sunfader ® contains: ACTIVES: Hydroquinone, USP 4% (40mg/g); Octinoxate, USP 7.5%; Oxybenzone, USP 5.5% INACTIVES: ascorbic acid, BHT, butylparaben, cetyl alcohol, disodium EDTA, glycerin, methylparaben, propylparaben, saponins, sodium lauryl sulfate, sodium metabisulfite, stearyl alcohol, tocopheryl acetate, water (aqua)

Drug Facts

Composition & Profile

Active Ingredients
Active ingredients Purpose Homosalate 10% Sunscreen Octisalate 5% Sunscreen Zinc Oxide 16.5% Sunscreen
Inactive Ingredients
Inactive ingredients Water (Aqua) C15-19 Alkane Octyldodecyl Neopentanoate Polymethylsilsesquioxane Sorbitan Olivate Silica Polyglyceryl-6 Polyrininoleate Sodium Chloride Xanthan Gum Glycerin Hydroxyacetophenone Disodium EDTA 1 2-Hexanediol Caprylyl Glycol Sodium Hydroxide Triethoxycaprylsilane Polyhydroxystearic Acid Disteardimonium Hectorite Polyglyceryl-2 Isostearate Euphorbia Cerifera (candelilla) Wax Beeswax Dimethicone
Strengths
57 g 28 g 10 % 5 % 16.5 %
Treats Conditions
Indications And Usage For The Gradual Bleaching Of Hyperpigmented Skin Conditions Such As Chloasma Melasma Freckles Senile Lentigines And Other Unwanted Areas Of Melanin Hyperpigmentation Uses Helps Prevent Sunburn If Used As Directed With Other Sun Protection Measures See Directions Decreases The Risk Of Skin Cancer And Early Skin Aging Caused By The Sun
Pill Appearance
Color: white

Identifiers & Packaging

Container Type BOTTLE
Packaging

HOW SUPPLIED Obagi Nu-Derm ® Clear is available as follows: Net wt. 2 oz. (57 g) bottle NDC 62032-101-36 Obagi Nu-Derm Blender ® is available as follows: Net wt. 2 oz. (57 g) bottle NDC 62032-100-36 Net wt. 1 oz. (28 g) bottle NDC 62032-100-10 Obagi Nu-Derm Sunfader ® is available as follows: Net wt. 2 oz. (57 g) bottle NDC 62032-116-36 Store at controlled room temperature: 15° to 25°C (59° to 77°F). Keep out of direct sunlight. 1-800-636-7546 Figure; PRINCIPAL DISPLAY PANEL - Kit Carton NDC# 62032-529-06 OBAGI ® MEDICAL NORMAL DRY Skin Transformation Kit Principal Display Panel - Kit Carton

Package Descriptions
  • HOW SUPPLIED Obagi Nu-Derm ® Clear is available as follows: Net wt. 2 oz. (57 g) bottle NDC 62032-101-36 Obagi Nu-Derm Blender ® is available as follows: Net wt. 2 oz. (57 g) bottle NDC 62032-100-36 Net wt. 1 oz. (28 g) bottle NDC 62032-100-10 Obagi Nu-Derm Sunfader ® is available as follows: Net wt. 2 oz. (57 g) bottle NDC 62032-116-36 Store at controlled room temperature: 15° to 25°C (59° to 77°F). Keep out of direct sunlight. 1-800-636-7546 Figure
  • PRINCIPAL DISPLAY PANEL - Kit Carton NDC# 62032-529-06 OBAGI ® MEDICAL NORMAL DRY Skin Transformation Kit Principal Display Panel - Kit Carton

Overview

Hydroquinone, USP 4% is 1, 4-benzenediol. The drug is freely soluble in water and in alcohol. Chemically, hydroquinone is designated as p-dihydroxybenzene; the empirical formula is C 6 H 6 O 2 ; molecular weight is 110.11 g/mol. The chemical structure is in the diagram below. Chemical Structure Each gram of Obagi Nu-Derm ® Clear contains: ACTIVE: Hydroquinone, USP 4% (40 mg/g) INACTIVES: ascorbic acid, BHT, butylparaben, cetyl alcohol, disodium EDTA, glycerin, lactic acid, methylparaben, propylparaben, saponins, sodium lauryl sulfate, sodium metabisulfite, stearyl alcohol, tocopheryl acetate, water (aqua) Each gram of Obagi Nu-Derm Blender ® contains: ACTIVE: Hydroquinone, USP 4% (40 mg/g) INACTIVES: ascorbic acid, BHT, cetyl alcohol, disodium EDTA, glycerin, lactic acid, methylparaben, phenyl trimethicone, PPG-2 myristyl ether propionate, propylparaben, saponins, sodium lauryl sulfate, sodium metabisulfite, TEA-salicylate, tocopheryl acetate, water (aqua) Each gram of Obagi Nu-Derm ® Sunfader ® contains: ACTIVES: Hydroquinone, USP 4% (40mg/g); Octinoxate, USP 7.5%; Oxybenzone, USP 5.5% INACTIVES: ascorbic acid, BHT, butylparaben, cetyl alcohol, disodium EDTA, glycerin, methylparaben, propylparaben, saponins, sodium lauryl sulfate, sodium metabisulfite, stearyl alcohol, tocopheryl acetate, water (aqua)

Indications & Usage

For the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines and other unwanted areas of melanin hyperpigmentation. Uses helps prevent sunburn If used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun

Dosage & Administration

A thin application should be applied once or twice daily or as directed by a physician. If no improvement is seen after three (3) months of treatment, use of this product should be discontinued. Sun exposure should be limited by using a sunscreen agent or protective clothing to cover bleached skin when using and after using this product in order to prevent darkening from reoccurring. Directions apply liberally 15 minutes before sun exposure use a water resistant sunscreen if swimming or sweating reapply at least every 2 hours Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: limit time in the sun, especially from 10 a.m.–2 p.m. wear long-sleeved shirts, pants, hats, and sunglasses children under 6 months: Ask a doctor

Warnings & Precautions
WARNINGS Hydroquinone is a skin-bleaching agent, which may produce unwanted cosmetic effects if not used as directed. The physician should be familiar with the contents of this insert before prescribing or dispensing this product. Test for skin sensitivity before using by applying a small amount to an unbroken patch of skin and check within 24 hours. Some users of this product may experience a mild skin irritation. If skin irritation becomes severe, stop use and consult a doctor. Close patient supervision is recommended. WARNINGS: Avoid contact with eyes, nose, mouth and lips. In case of accidental contact, patient should rinse thoroughly with water and contact a physician. Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure sustains melanocytic activity. Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people. Warnings For external use only Do not use on damaged or broken skin Stop use and ask a doctor if rash occurs When using this product keep out of eyes. Rinse with water to remove. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Contraindications

People with prior history of sensitivity or allergic reaction to this product or any of its ingredients should not use it. The safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established.

Adverse Reactions

No systemic adverse reactions have been reported. Occasional hypersensitivity (localized contact dermatitis) may occur, in which case the product should be discontinued and the physician notified immediately. To report SUSPECTED ADVERSE REACTIONS, contact Obagi Cosmeceuticals LLC, at 1-800-636-7546 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Purpose

Active ingredients Purpose Homosalate 10% Sunscreen Octisalate 5% Sunscreen Zinc Oxide 16.5% Sunscreen

Do Not Use

Do not use on damaged or broken skin

When Using

When using this product keep out of eyes. Rinse with water to remove.

Stop Use & Ask a Doctor

Stop use and ask a doctor if rash occurs

Keep Out of Reach of Children

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Storage & Handling

Store at controlled room temperature: 15° to 25°C (59° to 77°F). Keep out of direct sunlight. 1-800-636-7546 Figure Other information store at controlled room temperature: 15°C–25°C (59°F–77°F) protect this product from excessive heat and direct sun

Questions

Questions or comments? 1.800.636.7546 Monday–Friday 9 a.m.–4 p.m. Pacific Time


Similar Drugs

Related medications based on brand, generic name, substance, active ingredients.

View all similar drugs →